Revolution Medicines, Inc. is 22.0x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($30.74 B vs $1.40 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GLUE | RVMD |
|---|---|---|
| Market cap | $1.40 B | $30.74 B |
| US-listed rank | #2377 | #453 |
| Revenue (latest FY) | $123.67M | $0.00 |
| Net income (latest FY) | -$38.60M | -$1.13B |
| Net margin | -31.2% | - |
| SEC filings | 352 | 782 |
Revolution Medicines, Inc. is 22.0x more valuable than Monte Rosa Therapeutics, Inc. by market capitalization ($30.74 B vs $1.40 B).
In their latest fiscal years, Monte Rosa Therapeutics, Inc. reported $123.67M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Monte Rosa Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.